Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 pandemic increased some stress-related skin diseases but didn't affect others.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Some birth control pills increase young women's risk of blood clots more than others.

Marijuana use is linked to higher chances of needing treatment for urinary symptoms in men over 40.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Acne is more common in men with male pattern baldness due to increased hormone levels.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Men with depression and marijuana usage are more likely to be treated for lower urinary tract symptoms/benign prostatic hyperplasia.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Women with PCOS have more severe liver disease.

Psychological issues with skin problems worsen patients' lives and treatment.

St. John's Wort extract and oil safety in cosmetics is unclear; more data needed on photosensitization, toxicity, and human irritation.

Primary health care in Florianópolis mostly treated simple skin conditions, while secondary care handled more complex skin diseases.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.